GBR-13069

GBR-13069 is a drug that acts as a potent and selective dopamine reuptake inhibitor. It is primarily used in scientific research, and has been particularly important in studying the role of dopamine in the brain, and in the development of new treatments for conditions such as Parkinson's disease and drug addiction.

Pharmacology

GBR-13069 is a selective inhibitor of the dopamine transporter (DAT), which is responsible for the reuptake of dopamine in the brain. By blocking this transporter, GBR-13069 increases the amount of dopamine available in the brain, which can have a variety of effects depending on the specific brain regions involved.

Uses in Research

GBR-13069 has been used in a variety of research contexts. It has been particularly important in studying the role of dopamine in the brain, and in the development of new treatments for conditions such as Parkinson's disease and drug addiction. For example, it has been used to investigate the effects of increased dopamine availability on behavior, and to test the efficacy of potential new drugs for Parkinson's disease.

Side Effects

As with any drug, GBR-13069 can have side effects. These can include nausea, vomiting, and insomnia. However, because it is primarily used in research rather than in clinical practice, these side effects are typically managed by the researchers conducting the studies.

See Also

• Dopamine reuptake inhibitor
• Dopamine transporter
• Parkinson's disease
• Drug addiction

GBR-13069 Resources
Need Help Finding a Doctor? Need help finding a doctor or specialist anywhere in the world? Explore our world directory. WikiMD's DocFinder can assist you in locating millions of physicians.	Medical Knowledge Access the latest research - Most recent articles Ongoing trials.

Translate to: East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski